A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Clinical trial NCT03898791 · COMPLETED
Trial details
- NCT number
- NCT03898791
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-16
- Primary completion
- 2020-06-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.